Through the RT-qPCR analysis of clinical tissue samples, Higuchi et al. revealed that PDGFRB was significantly upregulated in stage II/III gastric cancer and was closely related to the poor 5-year survival rate and proliferation of cancer cells. The gene discussed is PDGFRB; the disease is cancer.